Maxicon Pharmaceuticals Private Limited
About Maxicon Pharmaceuticals Private Limited
Data last updated:
Maxicon Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 22 May 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24100DL2015PTC280621. Its GSTIN is 09AAKCM0509M1Z7 (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Suresh Chand Saini and Sapna Saini.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at X – 3137 Gali No. 4 Raghubar Pura II Gandhi Nagar, Delhi, India – 110031.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.39 Cr, a growth of 58% compared to the previous year. For the same year it recorded a net profit of ₹31.08 Lakh (net margin 13%) and EBITDA of ₹42.36 Lakh (EBITDA margin 17.7%). Revenue has grown at a compounded annual rate (CAGR) of 38% over three years and 27% over five years.
Court records list 2 cases involving the company, including 2 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Maxicon Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressX – 3137 Gali No. 4 Raghubar Pura II Gandhi Nagar, Delhi, India – 110031
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Maxicon Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Maxicon Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Maxicon Pharmaceuticals Private Limited, buy the company report.
Financials of Maxicon Pharmaceuticals Private Limited
FY 2025 filings availableMaxicon Pharmaceuticals Private Limited reported revenue of ₹2.39 Cr (up 58% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 27% over five years, including 58% growth in the latest year. EBITDA rose 507% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹42.36 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹31.08 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 17.7% | ||||
| Net Profit Margin | 13% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Maxicon Pharmaceuticals Private Limited, buy the company report.
Board of directors of Maxicon Pharmaceuticals Private Limited
Maxicon Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Suresh Chand Saini | Director | 22 May 2015 | 11 Years 5 Months | Current |
| Sapna Saini | Director | 22 May 2015 | 11 Years 5 Months | Current |
| Abhishek Sharma | Director | 27 Oct 2016 | 10 Years 0 Months | Current |
Auditor
Maxicon Pharmaceuticals Private Limited is audited by ALOK AGARWAL & CO for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ALOK AGARWAL & CO | FY 2018 | 008534C |
Shareholding
The shareholding of Maxicon Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Maxicon Pharmaceuticals Private Limited, buy the company report.
Legal cases
Maxicon Pharmaceuticals Private Limited has 2 court cases on record: 2 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 2 | 0 |
Cases on record (1 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, South Twenty Four Parganas, West Bengal | Civil suit | Filed against the company by Mankind Pharma Ltd and Anr | Disposed |
To see the full case history of Maxicon Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Maxicon Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Maxicon Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAKCM0509M1Z7 | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Maxicon Pharmaceuticals Private Limited, buy the company report.
Recent activity
Maxicon Pharmaceuticals Private Limited has 3 board changes on record since 2015: 3 appointments. The latest: Abhishek Sharma was appointed as Director on 27 Oct 2016.
Frequently asked questions
Maxicon Pharmaceuticals is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 22 May 2015 (11+ years old) and is registered under CIN U24100DL2015PTC280621.
Maxicon Pharmaceuticals has 3 current directors:
- Suresh Chand Saini - Director
- Sapna Saini - Director
- Abhishek Sharma - Director
The latest financial statements of Maxicon Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Maxicon Pharmaceuticals is 09AAKCM0509M1Z7, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Maxicon Pharmaceuticals is U24100DL2015PTC280621. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Maxicon Pharmaceuticals has 2 court cases on record: 2 filed against it.
Maxicon Pharmaceuticals was incorporated on 22 May 2015, making it 11+ years old. It is registered with the Registrar of Companies, Delhi.
Abhishek Sharma was appointed as Director on 27 Oct 2016. Sapna Saini was appointed as Director on 22 May 2015. Suresh Chand Saini was appointed as Director on 22 May 2015.
The registered office of Maxicon Pharmaceuticals is at X – 3137 Gali No. 4 Raghubar Pura II Gandhi Nagar, Delhi, India – 110031.
Maxicon Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.